JP7728784B2 - ストレプトコッカス・スイス血清型９、配列型１６に対する防御のためのワクチン - Google Patents

ストレプトコッカス・スイス血清型９、配列型１６に対する防御のためのワクチン

Info

Publication number
JP7728784B2
JP7728784B2 JP2022554800A JP2022554800A JP7728784B2 JP 7728784 B2 JP7728784 B2 JP 7728784B2 JP 2022554800 A JP2022554800 A JP 2022554800A JP 2022554800 A JP2022554800 A JP 2022554800A JP 7728784 B2 JP7728784 B2 JP 7728784B2
Authority
JP
Japan
Prior art keywords
streptococcus suis
serotype
sequence type
igm protease
suis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022554800A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023517684A5 (https=
JP2023517684A (ja
Inventor
ヤコブス，アントニウス・アルノルドゥス・クリスティアーン
Original Assignee
インターベット インターナショナル ベー． フェー．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インターベット インターナショナル ベー． フェー． filed Critical インターベット インターナショナル ベー． フェー．
Publication of JP2023517684A publication Critical patent/JP2023517684A/ja
Publication of JP2023517684A5 publication Critical patent/JP2023517684A5/ja
Application granted granted Critical
Publication of JP7728784B2 publication Critical patent/JP7728784B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2022554800A 2020-03-14 2021-03-12 ストレプトコッカス・スイス血清型９、配列型１６に対する防御のためのワクチン Active JP7728784B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20163206.4 2020-03-14
EP20163206 2020-03-14
PCT/EP2021/056285 WO2021185680A1 (en) 2020-03-14 2021-03-12 A vaccine for protection against streptococcus suis serotype 9, sequence type 16

Publications (3)

Publication Number Publication Date
JP2023517684A JP2023517684A (ja) 2023-04-26
JP2023517684A5 JP2023517684A5 (https=) 2024-02-28
JP7728784B2 true JP7728784B2 (ja) 2025-08-25

Family

ID=69844613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022554800A Active JP7728784B2 (ja) 2020-03-14 2021-03-12 ストレプトコッカス・スイス血清型９、配列型１６に対する防御のためのワクチン

Country Status (6)

Country Link
US (1) US12383610B2 (https=)
EP (1) EP4117721A1 (https=)
JP (1) JP7728784B2 (https=)
CN (1) CN115243715B (https=)
BR (1) BR112022017316A2 (https=)
WO (1) WO2021185680A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024528172A (ja) * 2021-08-03 2024-07-26 インターベット インターナショナル ベー． フェー． 様々な血清型のストレプトコッカス・スイスに対する防御のためのワクチン
CN113832068B (zh) * 2021-10-14 2023-07-25 河南兴华生物技术有限公司 链球菌菌株及防治猪链球菌病的疫苗

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019115741A1 (en) 2017-12-15 2019-06-20 Intervet International B.V. A vaccine for protection against streptococcus suis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201402264D0 (en) 2014-02-10 2014-03-26 Wellstream Int Ltd Composite
EP2949340A1 (en) * 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
US11155585B2 (en) 2015-07-09 2021-10-26 Intervacc Ab Vaccine against S. suis infection
EP3723794A1 (en) * 2017-12-15 2020-10-21 Intervet International B.V. A vaccine for protection against streptococcus suis
WO2020094762A1 (en) 2018-11-08 2020-05-14 Intervet International B.V. A vaccine for protection against streptococcus suis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019115741A1 (en) 2017-12-15 2019-06-20 Intervet International B.V. A vaccine for protection against streptococcus suis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Vaccine，2015年，Vol.33，p.2207-2212
Veterinary Immunology and Immunopathology，2012年，Vol.146，p.191-200

Also Published As

Publication number Publication date
CN115243715B (zh) 2025-12-16
US20240197851A1 (en) 2024-06-20
US12383610B2 (en) 2025-08-12
EP4117721A1 (en) 2023-01-18
CN115243715A (zh) 2022-10-25
BR112022017316A2 (pt) 2022-10-11
JP2023517684A (ja) 2023-04-26
WO2021185680A1 (en) 2021-09-23

Similar Documents

Publication Publication Date Title
CN111447945A (zh) 用于保护以抗猪链球菌的疫苗
JP7571015B2 (ja) 豚レンサ球菌感染防御のためのワクチン
EP3549600A1 (en) A vaccine for protection against streptococcus suis
US11167021B2 (en) Vaccine for protection against Streptococcus suis
JP7728784B2 (ja) ストレプトコッカス・スイス血清型９、配列型１６に対する防御のためのワクチン
US12023374B2 (en) Vaccine for protection against Streptococcus suis
JP7295223B2 (ja) 混合ワクチン
KR102819995B1 (ko) 연쇄상구균에 대한 보호를 위한 백신
RU2841376C1 (ru) Вакцина для защиты от streptococcus suis серотипа 9, тип последовательности 16
EP4380612A1 (en) A vaccine for protection against streptococcus suis of various serotypes
JP2024527138A (ja) 様々な血清型のストレプトコッカス・スイスに対して保護するためのワクチン
EP4380611A1 (en) A vaccine for protection against streptococcus suis of various serotypes
RU2802072C2 (ru) Вакцина для защиты от streptococcus suis
RU2777065C1 (ru) Комбинированная вакцина
WO2025040792A1 (en) Multivalent vaccine against swine infections
US20220339276A1 (en) A vaccine for protection against streptococcus suis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240219

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250311

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250606

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250805

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250813

R150 Certificate of patent or registration of utility model

Ref document number: 7728784

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150